1) Pegstim is indicated for: a) Reduction in the duration of neutropenia in patients treated with cytotoxic chemotherapy for malignancy b) Reduction in the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy c) Decrease the risk of febrile neutropenia in patients with non-myeloid malignancies d) All of the above 2) What is the dosing of Pegstim? a) 6 mg, 24 hour after the chemotherapy b) 6 mg, 24 hour before the chemotherapy c) 6 mg, 14 days before administration cytotoxic chemotherapy d) 6 mg, 14 weeks before administration cytotoxic chemotherapy

PSMO BOOTH ACTIVITY

tarafından
Yazdır
Yerleştir

Skor Tablosu

Görsel stil

Seçenekler

Şablonu değiştir

Otomatik olarak kaydedilen geri yüklensin mi: ?